Qiagen stock: buy or sell?

QGEN stock price: $28.49 1.10% At close on October 18th, 2019

Updated on:
October 18th, 2019

1

Qiagen shares grew 1.10% to $28.49 on Oct/18. Oct/18 was the 5th climbing day in a row, soaring 5.18%.

QIAGEN N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide. It offers sample technologies for plasmid deoxyribonucleic acid (DNA) purification, ribonucleic acid purification and stabilization, genomic and viral nucleic acid purification, DNA cleanup after polymerase chain reaction (PCR) and sequencing, and library preparation for sequencing applications; and assay technology solutions.

Should I buy Qiagen stock?

You can't be a successful trader if you don't follow a methodolgy or system that assist you in choosing companies and the correct market timing. Having a trading strategy helps to make decisions easier, quicker and with less hesitations. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.

Currently, Qiagen stock doesn't match any of these trading strategies, so our recommendation is not to buy.

Buy setupElegible
New all-time highNo
New 52 week highNo
Price crossing up 200d MANo
100d MA crossing up 200d MANo
This doesn't mean QGEN will slide in coming sessions, or it will not rise higher. Simply, it doesn't match our recommended trading systems.

Is Qiagen stock a buy?

Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness. At Stocks2.com, we collected 15 ratings published for QGEN stock in the last month.

The general sentiment of these ratings is bullish for QGEN stock, with 12 positive ratings.
Is QGEN a good stock to buy?
DateAnalyst / BrokerPrevious ratingCurrent rating
2019-8-1Goldman Sachs Groupn/aBuy
2019-7-26Deutsche Bankn/aBuy
2019-7-26Berenberg Bankn/aBuy
2019-7-24DZ Bankn/aNeutral
2019-7-12Exane BNP ParibasNeutralOutperform
2019-7-12BNP ParibasNeutralOutperform
2019-6-21Goldman Sachs Groupn/aBuy
2019-6-21Barclaysn/aOverweight
2019-6-21Barclaysn/aOverweight
2019-5-8Deutsche Bankn/aBuy
2019-5-7Goldman Sachs Groupn/aBuy
2019-4-12Deutsche Bankn/aBuy
2019-3-15UBS Groupn/aNeutral
2019-1-29Deutsche Bankn/aBuy
2019-1-21Jefferies Financial Groupn/aNeutral

Qiagen stock analysis

Daily outlook

Qiagen shares grew 1.10% to $28.49 on Oct 18th.

Qiagen shares grew 1.10% to $28.49 on Oct/18. Since August when QGEN stock price broke down the SMA200d line, it slid $-9.23 per share (-24.47%). QGEN marked a lower low and a lower high in the short term, defining a downward trend. Climbing above $32.43 would break this short term down trend and open possibilities for reversing this situation.

QGEN stock chart (daily)

Weekly outlook

After sliding a bloodcurdling -19.46% in a week last week, Qiagen closed this week at $28.49 and climbed a cool 5.21%. This week broke a red streak of 4 weeks.

Since late July, when QGEN stock price broke down the 40-weeks moving avarage line, it slid $-9.80 per share (-25.59%). Trading stocks that are below the 40-weeks (that is, 200-days) moving average mark is not recommended by many experts, as it indicates that the stock has not enough institutional support.

QGEN stock chart (weekly)

Qiagen stock price history

Qiagen IPO was on June 28th, 1996 at $1.93 per share1. Since then, QGEN stock surged a 1,376.20%, with a yearly average of 59.80%. If you had invested right after QGEN's IPO a $1,000 in Qiagen stock in 1996, it would worth $13,762.00 today.

1: Adjusted price after possible price splits or reverse-splits.

Qiagen stock historical price chart

QGEN stock reached 52-week highs on April at $41.55, and all-time highs 2000-07-17 with a price of 58.18.

Qiagen stock price target is $43.30

Predicting the price evolution of a stock or any financial instrument in a reliable and repeatable way is probably impossible. However, banks and other financial institutions analysts, with the help of lots of data and algorithms do their best to predict the stock prices movement. The accuracy of these stock price predictions is not very high, and you should not blindly believe and make decisions only based on what this ratings or price target predictions say. We detected 3 price targets for QGEN stock posted in the last month:
QGEN stock price predictions
DateAnalyst / BrokerActionPrevious targetCurrent targetDiff
2019-7-26Berenberg BankReiteratesn/a$40.00-
2019-6-21BarclaysReiterates$43.00$45.004.7%
2019-6-21BarclaysRaises Target$43.00$45.004.7%
(in average)$43.00$43.301.0%
The price target for Qiagen stock is $43.30, moving in a range between $45.00 and $40.00. In average, analysts' outlook on QGEN price forecast is stable from previous estimations.

Financials and fundamental analysis

Earnings date and Earnings per Share

After publishing its last earnings report on May, Qiagen . As soon as we get its actual EPS from the earnings report, we will extend this report.
QGEN earnings date and EPS evolution
QuarterReporting dateEstimated EPSActual EPSSurprise
2017-Q1-n/a0.3n/a
2017-Q2-n/a0.1n/a
2017-Q32017-11-060.320.320.0%
2017-Q42018-01-310.410.434.9%
2018-Q12018-05-020.240.268.3%
2018-Q22018-07-310.320.333.1%
2018-Q32018-10-290.330.356.1%
2018-Q42019-02-040.40.40.0%
2019-Q12019-05-010.26n/an/a
2019-Q2-n/an/an/a

Annual financial results

In 2018, Qiagen annual turnover soared a nice 5.95% to $1,501.85 M dollars from $1,417.54 marked in 2017. When comparing 2018 vs 2017, however, profit margin (that is, the net income divided by revenues) escalated a 9.83% to 12.68%.

Qiagen fiscal year ends in December, and to compare its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Qiagen TTM sales up to were $1,158.28 and earnings $158.09 million USD. If we compare this TTM figures with the last reported annuality, we can review Qiagen business evolution since December 2018: Annual revenues up to , compared to lastest yearly report, plunged a frightening -22.88%. In contrast, profit margin (net income/sales) stayed steady at 12.68%.

QGEN annual Sales and Income evolution
YearSalesYoYIncome/(margin)YoY
2013$1,300 M-$69 M5.3%-
2014$1,345 M3.44%$117 M8.7%68.86%
2015$1,281 M-4.74%$127 M9.9%8.98%
2016$1,338 M4.45%$80 M6.0%-36.74%
2017$1,418 M5.95%$40 M2.8%-49.76%
2018$1,502 M5.95%$190 M12.7%371.31%
TTM $1,158 M-22.88%$158 M13.6%-16.96%

Quarterly financial results

Qiagen reported million in sales for 2019-Q1, a -100.00% decline compared to previous quarter. Reported quarter earnings marked M with a profit margin of . Profit margin stayed stable a 0.00% compared to previous quarter when profit margin was 15.12%. When comparing turnover to same quarter last year, Qiagen sales marked a hair-raising decrease and collapsed a -100.00%.
QGEN quarterly Sales and Income evolution
QuarterSales1QoQ2Income1/(margin)QoQ2
2017-Q1$308 M-$18 M5.7%-
2017-Q2$349 M13.42%$14 M4.0%-20.96%
2017-Q3$364 M4.29%$48 M13.3%247.56%
2017-Q4$397 M9.04%$-40 M-10.0%-181.87%
2018-Q1$344 M-13.43%$32 M9.4%-181.36%
2018-Q2$377 M9.79%$37 M9.8%14.00%
2018-Q3$378 M0.19%$60 M16.0%63.85%
2018-Q4$403 M6.68%$61 M15.1%1.04%

Qiagen ownership

When you are planning to buy shares of a company, it's worth to review its ownership structure.

Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Qiagen, 2.76% of all outstanding shares are owned by its staff.

In case of Qiagen stock, 72.73% of its shares are held by institutions (mutual funds, pension funds, big banks and other large financial institutions). Bearish positions for QGEN stock account 0.00%, no big difference from last month.

The following table compares ownership indicators for other stocks related to Qiagen:

QGENBDXGEGHDXGNMK
Market cap$6.5 B$69.8 B$78.2 B$2.6 B$329.7 M
Total shares226.5 M270.0 M8,730.0 M37.6 M57.4 M
Float shares217.7 M269.1 M8,710.0 M25.0 M45.2 M
  - Institutional holdings (%)72.7%87.5%58.6%86.9%95.9%
  - Insider holdings (%)2.8%0.3%0.2%2.8%6.6%
Shares in short selling0.0%0.0%0.0%0.0%0.0%

Qiagen summary

Friday, October 18th, 2019
Open$28.36
Close$28.49
Day range$28.29 - $28.64
Previous close$28.18
Session gain1.10%
Average true range$1.18
50d mov avg$32.71
100d mov avg$35.96
200d mov avg$37.17
Daily patternlb06a
Weekly pattern

Qiagen performance

To better understand Qiagen performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare Qiagen performance to Becton, Dickinson and, General Electric, Genomic Health, GenMark Diagnostics, Hologic, Bio-Techne and Thermo Fisher Scientific:
Stock3m6m12m
QGENQiagen-27.95%-25.61%-20.66%
BDXBecton, Dickinson...3.40%14.18%9.98%
GEGeneral Electric-10.67%-3.97%-25.46%
GHDXGenomic Health25.35%13.29%8.94%
GNMKGenMark Diagnosti...-6.82%-18.00%-1.71%
HOLXHologic3.44%15.05%22.29%
TECHBio-Techne-4.24%6.21%13.58%
TMOThermo Fisher Sci...-2.84%8.47%24.23%

Qiagen competitors

We picked a few stocks to conform a list of Qiagen competitors to examine if you are interested in investing in QGEN: